Why the study?
Does radiofrequency catheter ablation of VF-triggering PVCs prevent recurrent ventricular fibrillation in a patient with Brugada syndrome and drug-resistant electrical storm?
Does radiofrequency catheter ablation of VF-triggering PVCs prevent recurrent ventricular fibrillation in a patient with Brugada syndrome and drug-resistant electrical storm?
Radiofrequency catheter ablation of VF-triggering PVCs may be an effective treatment strategy for drug-resistant electrical storm in patients with Brugada syndrome.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for RFCA of PVC triggers in Brugada storm; prospective studies needed before clinical adoption.
The case of a 41-year-old man with Brugada syndrome (BS) who suffered electrical storms (ES) of ventricular fibrillation (VF) is presented. Although intravenous infusion of isoproterenol (ISP) suppressed the VF occurrence, he consistently experienced recurrence of VF following discontinuation of ISP infusion. Quinidine and cilostazol were ineffective. An analysis of VF episodes on electrocardiogram monitoring revealed that the QRS morphology of the first beat of all VF episodes was identical to that of premature ventricular complexes (PVCs) with a left bundle branch-block morphology and inferior axis, which occurred repetitively before the episodes of VF and were recorded throughout the day. In addition, stored electrograms from the implantable cardioverter defibrillator showed that the first beat of all VF episodes had the same morphology. On electrophysiological study, the VF-triggering PVC was found to originate from the posterior portion of the right ventricular outflow tract area and their elimination, which was achieved with radiofrequency catheter ablation (RFCA), resulted in the suppression of ES. Although several other PVCs were still observed, the patient has been free of VF during the 29-month follow-up period. This case indicates that RFCA of VF-triggering PVCs may be useful in the treatment of drug-resistant ES in patients with BS.
No takes yet. Share an insight, caveat, or question.
Nakagawa et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: